Introduction
Successful development and marketing of an automated product requires accurate identification of the needs that the instrument can satisfy and the expression of those needs as parameters for product design. Once these parameters are set the manufacturer must develop a product prototype to satisfy them. Finally, extensive field testing of the prototype must be carried out before making the instrument commercially available. This is very critical, especially in healthcare automation.
The Du Pont 'aca' analyser
The development of the Du Pont 'aca', a clinical analyser that automates 42 tests on blood serum and body fluids, illustrates the above process. The heart of the 'aca' system is the analytical test pack containing prepackaged reagents in their stable form. On top of the pack is a plastic header. This carries a binary code which enables the instrument to identify the test being run. On the header is also imprinted the name of the test. The plastic pack which also serves as a test cuvette in which the chemical analysis takes place is shown in Figure 1 . minutes and thereafter every 37 74 seconds. The test report appears with the initial information recorded on the patient and a digital print of the results of the tests processed on that particular patient. The system design is shown in Figure 2 .
User requirements
In developing the design parameters for the 'aca' Du Pont based its decisions on user requirements; this paper will use as an example those of STAT or emergency testing which is the most demanding application of automation. These requirements were ranked in priority order as assessed by the development team after extensive discussions with clinical laboratory personnel.
(1) Quick turn-round time. STAT testing demands quick results. The plan therefore was to develop a system that would provide the first test results in less than eight minutes and successive test results every 37 to 74 seconds.
(2) Round-the-clock availability. The second requirement in STAT testing is that the automated system be available 24 hours a day, 7 days a week. The design parameter was that the 'aca' always be on standby when not in use with no start-up or shut-down time required before analyses can be commenced.
(3) Minimum staffing. It is difficult to have skilled technologists available at all times, particularly at night and weekends. Therefore, the third user requirement is for a system that is relatively easy to use. The matching design parameter of the 'aca' was simplicity of operation with minimum operator involvement.
(4) Accuracy and precision. Because STAT tests are often the most critical tests the fourth user requirement is a high degree of accuracy and precision. The design parameter set was that a coeficient of variation equal to or less than 5 percent on enzyme tests and equal to or less than 3 percent on chemical tests should be obtained in routine use. Du Pont also provides the use of reference methodology in chemistry procedure development. [2] . Therefore, the information from the evaluations was widely disseminated for study by clinical laboratory personnel.
Although field evaluation is very expensive and time consuming, it is vital. It is absolutely imperative that the manufacturer does these evaulations so that the buyer of the equipment does not have to. The advantage from the buyer's standpoint is that the system has been thoroughly evaluated, so it can be rapidly put into routine clinical use. Field evaluation is also critical from the standpoint of the manufacturer. Earlier users will provide a satisfied referral base which is a major factor in the success of a new product.
Requirements upon marketing
Once the product has been launched commercially, the manufacturer must address a different set of requirements and spend considerable resources to satisfy them. In clinical laboratory automation, the first of these needs is service.
Using the Du Pont 'aca' as an example, the most stringent service requirements that apply to STAT market service were matched against the programme parameters of manufacture; these are discussed below.
(1) Instrument reliability. The first service requirement is for minimum downtime, which means a manufacturer must place a high priority on instrument reliability. Du Pont studies show that the 'aca' system is operative about 98 percent of the time. Du Pont also has a retrofitting programme for the 'aca'. Developments in the design of the 'aca' that improve reliability are retrofitted to all instruments in the field. By continuously improving the instrument's reliability, the downtime is further minimised.
(2) Round-the-clock servicing. In addition, a very extensive and expensive servicing programme ensures minimum downtime in STAT testing automation. Because the 'aca' system operates 24 hours a day, 7 days a week, around-the-clock service is required. This is handled through a large network of satellite service engineers, backed up by regional and area service centres.
(3) Modular components. The 'aca' system design is modular so that parts can be easily replaced. The service representative doesn't have to fix the part on site but, rather, can interchange the necessary part to get the system back in operation quickly. To ensure that parts are available when needed, Du Pont has set up regional parts depots at several major airports. Once a service engineer has contacted a laboratory, identified the problem and isolated it to one component, a call to the regional parts depot will have the necessary component on the next plane, thus ensuring minimum downtime. Very important to the training programme are readable manuals. The 'aca' manuals have been tested and are easy to follow; they are used as part of the training process and to answer questions. There is little likelihood they simply sit on the shelf.
Staying up to date
Another area that is extremely important in developing a commercial product is the manufacturer's obligation to maintain the state-of-the-art technology for the user. This is especially critical in clinical laboratory automation, which is a fast-changing, high-technology area. 
Conclusion
In summary, a manufacturer of analytical instruments must first identify the requirements in the clinical laboratory and then develop the product that mets them. Second, the manufacturer must conduct extensive field evaluations of the product prior to marketing to ensure that the first purchasers can rapidly incorporate the product into routine clinical use.
Third, once a commercial instrument is available, the manufacturer must commit large resources to service, training and maintaining the state-of-the-art tchnology. Finally, the manufacturer must provide accurate representation and contributions to professional healthcare societies.
